Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Tattersall

Showing results (51-60 of 288) with videos related to

Pageof 29
Sort By:
Australian Health Review : a Publication of the Australian Hospital Association|April 11, 1982
Cost considerations in cancer chemotherapyM H Tattersall, M L Friedlander
European Journal of Cancer & Clinical Oncology|March 1, 1983
Assessment of antimetabolite cytotoxicity: a comparison of clonogenic assays and tritiated deoxyuridine incorporationD J Perez, M H Tattersall
The Medical Journal of Australia|February 15, 1993
Oncology curricula in AustraliaM H Tattersall, A O Langlands
Australian and New Zealand Journal of Medicine|August 1, 1995
Tamoxifen flare--an unusual case of hypercalcaemia and transient rapidly progressive pancytopeniaP M Ellis, M H Tattersall
Lancet (London, England)|January 5, 1985
Doing the best for the cancer patientJ S Tobias, M H Tattersall
Molecular Pharmacology|July 1, 1982
The metabolic basis of deoxyuridine cytotoxicity. Studies of cultured human lymphoblastsD J Perez, M H Tattersall
European Journal of Cancer & Clinical Oncology|December 1, 1982
Counting the costs of cancer therapyM L Friedlander, M H Tattersall
Cancer Research|April 1, 1981
Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometryI W Taylor, M H Tattersall
Medical and Pediatric Oncology|January 1, 1990
Diethylstilbestrol revisited in advanced breast cancer managementM J Boyer, M H Tattersall
The Medical Journal of Australia|October 14, 1985
Recent advances in the prevention or reduction of cytotoxic-induced emesisJ H Kearsley, M H Tattersall
Pageof 29

Showing results (51-60 of 288) with videos related to

Sort By:
Pageof 29
Australian Health Review : a Publication of the Australian Hospital Association|April 11, 1982
Cost considerations in cancer chemotherapyM H Tattersall, M L Friedlander
European Journal of Cancer & Clinical Oncology|March 1, 1983
Assessment of antimetabolite cytotoxicity: a comparison of clonogenic assays and tritiated deoxyuridine incorporationD J Perez, M H Tattersall
The Medical Journal of Australia|February 15, 1993
Oncology curricula in AustraliaM H Tattersall, A O Langlands
Australian and New Zealand Journal of Medicine|August 1, 1995
Tamoxifen flare--an unusual case of hypercalcaemia and transient rapidly progressive pancytopeniaP M Ellis, M H Tattersall
Lancet (London, England)|January 5, 1985
Doing the best for the cancer patientJ S Tobias, M H Tattersall
Molecular Pharmacology|July 1, 1982
The metabolic basis of deoxyuridine cytotoxicity. Studies of cultured human lymphoblastsD J Perez, M H Tattersall
European Journal of Cancer & Clinical Oncology|December 1, 1982
Counting the costs of cancer therapyM L Friedlander, M H Tattersall
Cancer Research|April 1, 1981
Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometryI W Taylor, M H Tattersall
Medical and Pediatric Oncology|January 1, 1990
Diethylstilbestrol revisited in advanced breast cancer managementM J Boyer, M H Tattersall
The Medical Journal of Australia|October 14, 1985
Recent advances in the prevention or reduction of cytotoxic-induced emesisJ H Kearsley, M H Tattersall
Pageof 29